Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

Localized prostate cancer (PCa) is a clinically heterogeneous disease, which presents with variability in patient outcomes within the same risk stratification (low, intermediate or high) and even within the same Gleason scores. Genomic tools have been developed with the purpose of stratifying patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Moschini, Marco, Spahn, Martin, Mattei, Agostino, Cheville, John, Karnes, R. Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820857/
https://www.ncbi.nlm.nih.gov/pubmed/27044421
http://dx.doi.org/10.1186/s12916-016-0613-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820857/
https://www.ncbi.nlm.nih.gov/pubmed/27044421
http://dx.doi.org/10.1186/s12916-016-0613-7

Ejemplares similares